Erchonia Donates One Hundred and Fifty Thousand Dollars’ worth of Low-Level Lasers to the New York College of Podiatric Medicine & Foot Center of New York

Posted by & filed under Press Releases.

Pain-Free, Non-Surgical Laser Treatment Options   MELBOURNE, Fla. (PRWEB) July 25, 2018 We are pleased to announce New York College of Podiatric Medicine (NYCPM) & Foot Center of New York’s (FCNY) acquisition of several Erchonia low-level lasers, including both Lunula Lasers and FX 635 Lasers.  NYCPM provides unrivaled excellence in podiatric medical education and clinical… Read more »

FDA Market Clears Erchonia’s FX 635 Laser for Chronic Low Back Pain

Posted by & filed under Press Releases.

First and Only FDA Market Cleared Low-Level Laser Treatment Option Melbourne, FL (PRWEB) July 17, 2018 Erchonia Corporation announces another successful clinical trial that has resulted in the granting of an FDA 510(k) market clearance for chronic low back pain of musculoskeletal origin. This grants another first for Erchonia, which started the low-level laser category… Read more »

Laser Collaboration, 33 Partners from Around the Globe Represented ~ Erchonia 2018

Posted by & filed under Press Releases.

World’s Laser Therapy Advocates Convene in Orlando, FL, USA on May 3rd-4th, 2018   MELBOURNE, FLA. (PRWEB) MAY 01, 2018 We are verging on a global precipice: the increase in the number of debilitating brain diseases is growing exponentially, obesity rates are skyrocketing, more than ever before, patients who experience pain are becoming addicted to opioids…. Read more »

Low Level Laser Therapy for 360°- Degree Body Sculpting

Posted by & filed under Press Releases.

Michael H. Gold, M.D., FAAD from Gold Skin Care Center presenting Thursday 5th April @ 10:00AM at AWMC 2018 ~ Monaco.     Verjú LLLT by Erchonia, FDA Cleared for circumferential reduction of the waist, hips and thighs and temporary reduction in the appearance of cellulite will be featured on the programme at the Aesthetic… Read more »

Inside-Out Health: A Revolutionary Approach to Your Body (Advanced Seminar)

Posted by & filed under Press Releases.

Presented by: Dr. Robert Silverman November 19th-20th, 2016 – Indianapolis, IN Co-sponsored by: Erchonia Corporation & Northwestern Health Sciences University ~12 CE Hours Applied~  About the Seminar Join Dr. Silverman as he explores the process of implementing advanced laser protocols into your practice. He will share in-office tools, hands-on laser protocols, nutrition protocols and proven… Read more »

Nail Fungus Sufferers Find Relief in New Laser Treatment

Posted by & filed under Press Releases.

Lunula receives FDA approval, launches With the summer fun and flip flop season in full swing, those suffering from discolored toenails start to worry about wh at others think of their feet. Toenail fungus sufferers can now enjoy clear nail beds with the FDA 510(k) approval of the Lunula Laser, an Erchonia Corporation low-level laser…. Read more »

Erchonia Receives 7th FDA Market Clearance for Non Invasive Fat Loss

Posted by & filed under Press Releases.

Erchonia Receives 7th FDA Market Clearance for Non Invasive Fat Loss New once a week protocol allows for more treatment flexibility Erchonia announces today that they have received their 7th 510(k) market clearance and the 2nd in 2015 from the US FDA for non-invasive fat loss which is measured by circumference reduction. Erchonia has also been published 20… Read more »

Erchonia receives patent for noninvasive fat reduction.

Posted by & filed under Press Releases.

Patent no. US 8, 932,338B2- a noninvasive method of reducing fat from targeted regions of a patient’s body by applying low-level laser energy externally through the skin of the patient to the targeted areas. The laser works by applying sufficient energy to release intracellular fat into the interstitial space. The released intra-cellular fat is removed… Read more »

FDA Clears Erchonia’s New FX635 Laser for Chronic Heel Pain from Plantar Fasciitis

Posted by & filed under Press Releases.

“This new technology is a breakthrough for chronic heel pain sufferers, because it offers pain-free treatment with no known side effects or contraindications. “   Erchonia today announces the U.S. Food and Drug Administration (FDA) has granted the company 510 (k) clearance to market FX635, its new low level laser for the relief of chronic heel… Read more »

Results of Erchonia’s Lunula Laser’s Clinical Trial for the Noninvasive Treatment of Nail Fungus Published in Podiatry Review

Posted by & filed under Press Releases.

Erchonia today announces that the preliminary results of an ongoing clinical trial testing its Lunula laser for the noninvasive treatment of nail fungus have been published in the latest issue of the medical journal Podiatry Review.  “I am pleased to say the current data we are obtaining substantiates the Lunula laser as a safe and… Read more »